Document Type : Case Report

Authors

1 Lecturer of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt

2 Assistant lecturer of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt

Abstract

Introduction: Organophosphorus poisoning (OP) represents a significant public health issue, particularly in developing countries, due to its extensive availability and high toxicity. Standard management includes atropine and oximes such as Toxogonin; however, emerging evidence suggests potential adverse effects associated with oximes.
Case presentation: This case report examines the uncommon occurrence of acute kidney injury (AKI) in a 64-year-old Egyptian farmer following accidental dermal and inhalational exposure to OP pesticides. The patient presented with symptoms of OP poisoning, including dizziness, sweating, and fasciculations. Initial treatment with atropine and Toxogonin (obidoxime) resulted in temporary symptomatic improvement. Nevertheless, renal function progressively deteriorated after initiating Toxogonin therapy, evidenced by elevated urea and creatinine levels. Renal impairment coincided temporally with Toxogonin administration and improved following its cessation.
Discussion: Potential mechanisms of Toxogonin-induced AKI include direct nephrotoxicity, altered renal perfusion, or immune-mediated injury. Other causes, such as rhabdomyolysis, systemic hypotension, or intrinsic OP nephrotoxicity, were ruled out to reinforce the likelihood of oxime-related renal impairment. While oximes are essential in OP poisoning management, this case emphasizes the necessity for clinical vigilance concerning their potential nephrotoxic effects.
Conclusion: The findings highlight the need to reassess the use of oximes, especially in patients with pre-existing renal conditions. Furthermore, additional research is required to elucidate the mechanisms and determine risk factors associated with oxime-induced nephrotoxicity.

Keywords

Main Subjects

  1. Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315–35.
  2. Farahat TM, Shaheen HM, Sanad ZF, Frag NA. Knowledge, attitudes, and practices of organophosphorus pesticide exposure among women affiliated to the Manshat Sultan Family Health Center (rural area) in Menoufia governorate: an intervention study. Menoufia medical journal. 2016 Jan 1;29(1):115.
  3. Saeed NM, Ghanem M, Alhoshy HA, Atef M. A Five-Year Study on the Profile of Acute Poisoning Cases Admitted to Poison Center, Alexandria, Egypt. Asia pac j med toxicol. 2023;12(2): 42-48.
  4. Epidemiological Study of Organophosphorus Compounds Insecticides  Types Related To  Acutely Intoxicated Patients Presented To Poison Control Center(PCC-ASU)–Egypt. e-ISSN: 2319-2402,p- ISSN: 2319-2399.Volume 10, Issue 6 Ver. III (Jun. 2016), PP 72-78 www.iosrjournals.or
  5. Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008, 371:597-607. 1016/S0140-6736(07)61202-1
  6. Mumford H, Troyer JK. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs. Toxicol Lett, 2011; 206:29–34.
  7. Jokanović M. Neurotoxic effects of organophosphorus pesticides and possible association with neurodegenerative diseases in man: A review. Toxicology. 2018 Dec 1;410:125–31.
  8. Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci. 2006;249:76–85. https://doi.org/10.1016/j.jns.2006.06.007.
  9. Zafar R, Munawar K, Nasrullah A, Haq S, Ghazanfar H, Sheikh AB, et al. Acute renal failure due to organophosphate poisoning: a case report. Cureus. 2017 Jul;9(7): e1523.
  10. Agostini M, Bianchin A. Acute renal failure from organophosphate poisoning a case of success with haemofiltration. Hum Exp Toxicol. 2003;22:165–67. doi: 10.1191/0960327103ht343cr
  11. Yurumez Y, Ikizceli I, Sozuer EM, et al. Effect of interleukin-10 on tissue damage caused by organophosphate poisoning. Basic Clin Pharmacol Toxicol. 2007;100:323–327. doi: 10.1111/j.1742-7843.2007.00049.x. 
  12. Ranjan A, Jindal T. Toxicology of organophosphate poisoning. Springer International Publishing; 2022.
  13. Kobrlova T, Korabecny J, Soukup O. Current approaches to enhancing oxime reactivator delivery into the brain. Toxicology. 2019 Jul 1;423:75-83.
  14. Bentur Y, Nutenko I, Tsipiniuk A, Raikhlin-Eisenkraft B, Taitelman U. Pharmacokinetics of obidoxime in organophosphate poisoning associated with renal failure. J Toxicol Clin Toxicol. 1993 Jan 1;31(2):315-22.
  15. Sidell FR, Groff WA. Toxogonin: blood levels and side effects after intramuscular administration in man. J Pharm Sci. 1970 Jun;59(6):793-7.
  16. Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015 Spring;15(1):58-69. PMID: 25829882; PMCID: PMC4365849.